Editas Medicine (EDIT) Leases (2019 - 2025)
Editas Medicine (EDIT) has disclosed Leases for 7 consecutive years, with $17.6 million as the latest value for Q3 2025.
- Quarterly Leases fell 50.79% to $17.6 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $17.6 million through Sep 2025, down 50.79% year-over-year, with the annual reading at $32.6 million for FY2024, 3.34% down from the prior year.
- Leases for Q3 2025 was $17.6 million at Editas Medicine, down from $19.0 million in the prior quarter.
- The five-year high for Leases was $43.6 million in Q4 2022, with the low at $17.6 million in Q3 2025.
- Average Leases over 5 years is $29.5 million, with a median of $30.3 million recorded in 2021.
- The sharpest move saw Leases soared 68.45% in 2023, then tumbled 50.79% in 2025.
- Over 5 years, Leases stood at $26.2 million in 2021, then surged by 66.77% to $43.6 million in 2022, then fell by 22.84% to $33.7 million in 2023, then decreased by 3.34% to $32.6 million in 2024, then plummeted by 45.99% to $17.6 million in 2025.
- According to Business Quant data, Leases over the past three periods came in at $17.6 million, $19.0 million, and $26.4 million for Q3 2025, Q2 2025, and Q1 2025 respectively.